Posted on 22/03/08
Recall issued for heparin marketed in Canada
Canada has been drawn into the ever-widening scandal surrounding a commonly used blood thinner contaminated with a drug that can provoke life-threatening allergic reactions.Health Canada said yesterday that testing had revealed that heparin products marketed in Canada by B. Braun Medical Inc. of Mississauga, Ont., were tainted.
The full text of this article has 567 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
